Evidence map›Paper›PMID 37242441›Full record

ArticlePharmaceuticals (Basel, Switzerland)2023

Detection and Quantification of Some Ethanol-Producing Bacterial Strains in the Gut of Mouse Model of Non-Alcoholic Fatty Liver Disease: Role of Metformin.

Mohamed Abouelkheir, Ibrahim Taher, Amira S R Eladl, Dalia A Shabaan, Mona F M Soliman, Ahmed E Taha

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Pharmaceuticals (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.1field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 2 countries.

Mohamed AbouelkheirDepartment of Pharmacology and Therapeutics, College of Medicine, Jouf University, Sakaka 72388, Saudi Arabia.
Ibrahim TaherMicrobiology and Immunology Unit, Department of Pathology, College of Medicine, Jouf University, Sakaka 72388, Saudi Arabia.ORCID 0000-0003-2790-6972
Amira S R EladlDepartment of Pharmacology, College of Medicine, Mansoura University, Mansoura 35516, Egypt.
Dalia A ShabaanMedical Histology and Cell Biology Department, Faculty of Medicine, Mansoura University, Mansoura 35516, Egypt.
Mona F M SolimanMedical Histology and Cell Biology Department, Faculty of Medicine, Mansoura University, Mansoura 35516, Egypt.
Ahmed E TahaMicrobiology and Immunology Unit, Department of Pathology, College of Medicine, Jouf University, Sakaka 72388, Saudi Arabia.ORCID 0000-0002-5766-4495
Mansoura University · EGDamietta University · EGJouf University · SA

Funding

Al Jouf University DSR2020-04-515
6 · The paper itself

Abstract

Ethanol-producing dysbiotic gut microbiota could accelerate the progress of non-alcoholic fatty liver disease (NAFLD). Metformin demonstrated some benefits in NAFLD. In the present study, we tested the ability of metformin to modify ethanol-producing gut bacterial strains and, consequently, retard the progress of NAFLD. This 12-week study included forty mice divided into four groups (

Indexed as

Escherichia coliethanolgut microbiotaKlebsiella pneumoniaemetforminnon-alcoholic fatty liver disease

Identifiers

PMID37242441
PMCPMC10222308
OpenAlexW4367298782

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.